Slides
Page 1
RNAi POUNDTABLES ZILEBESIRAN An Investigational RNAi Therapeutic for Patients with Hypertension and High Cardiovascular Risk September 17 , 2026 Alnylam 2026 Alnylam Pharmaceuticals , Inc.
Loading workspace
RNAi POUNDTABLES ZILEBESIRAN An Investigational RNAi Therapeutic for Patients with Hypertension and High Cardiovascular Risk September 17 , 2026 Alnylam 2026 Alnylam Pharmaceuticals , Inc.
Your watchlist and earnings event details are available after you sign in.